Selected research
Market Structure
Global Sanger Sequencers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Sanger Sequencers market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Sanger Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Sanger Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sanger Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Sanger Sequencers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sanger Sequencers include Danaher, Promega, Denogen (Beijing) Bio-Sci&Tech, Ningbo HEALTH Gene Technologies, Thermo Fisher Scientific and Superyears Gene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Sanger Sequencers market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Sanger Sequencers and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sanger Sequencers sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sanger Sequencers market size, projected growth trends, production technologies, key applications, and end-use industries.
Sanger Sequencers Segment by Company
Danaher
Promega
Denogen (Beijing) Bio-Sci&Tech
Ningbo HEALTH Gene Technologies
Thermo Fisher Scientific
Superyears Gene
Sanger Sequencers Segment by Type
4-Channel
8-Channel
Others
Sanger Sequencers Segment by Application
Clinical Testing
Scientific Research
Sanger Sequencers Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sanger Sequencers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sanger Sequencers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sanger Sequencers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Sanger Sequencers market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sanger Sequencers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sanger Sequencers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Sanger Sequencers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 4-Channel
- 8-Channel
- Others
Applications
- Clinical Testing
- Scientific Research
Companies covered
- Danaher
- Promega
- Denogen (Beijing) Bio-Sci&Tech
- Ningbo HEALTH Gene Technologies
- Thermo Fisher Scientific
- Superyears Gene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Sanger Sequencers Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Sanger Sequencers Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Sanger Sequencers Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Sanger Sequencers Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Sanger Sequencers Market Dynamics
- 2.1 Sanger Sequencers Industry Trends
- 2.2 Sanger Sequencers Industry Drivers
- 2.3 Sanger Sequencers Industry Opportunities and Challenges
- 2.4 Sanger Sequencers Industry Restraints
3 Sanger Sequencers Market by Manufacturers
- 3.1 Global Sanger Sequencers Revenue by Manufacturers (2021-2026)
- 3.2 Global Sanger Sequencers Sales by Manufacturers (2021-2026)
- 3.3 Global Sanger Sequencers Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Sanger Sequencers Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sanger Sequencers Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Sanger Sequencers Manufacturers, Product Type & Application
- 3.7 Global Sanger Sequencers Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sanger Sequencers Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sanger Sequencers Players Market Share by Revenue in 2025
- 3.8.3 2025 Sanger Sequencers Tier 1, Tier 2, and Tier 3
4 Sanger Sequencers Market by Type
- 4.1 Sanger Sequencers Type Introduction
- 4.1.1 4-Channel
- 4.1.2 8-Channel
- 4.1.3 Others
- 4.2 Global Sanger Sequencers Sales by Type
- 4.2.1 Global Sanger Sequencers Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Sanger Sequencers Sales by Type (2021-2032)
- 4.2.3 Global Sanger Sequencers Sales Market Share by Type (2021-2032)
- 4.3 Global Sanger Sequencers Revenue by Type
- 4.3.1 Global Sanger Sequencers Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Sanger Sequencers Revenue by Type (2021-2032)
- 4.3.3 Global Sanger Sequencers Revenue Market Share by Type (2021-2032)
5 Sanger Sequencers Market by Application
- 5.1 Sanger Sequencers Application Introduction
- 5.1.1 Clinical Testing
- 5.1.2 Scientific Research
- 5.2 Global Sanger Sequencers Sales by Application
- 5.2.1 Global Sanger Sequencers Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Sanger Sequencers Sales by Application (2021-2032)
- 5.2.3 Global Sanger Sequencers Sales Market Share by Application (2021-2032)
- 5.3 Global Sanger Sequencers Revenue by Application
- 5.3.1 Global Sanger Sequencers Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Sanger Sequencers Revenue by Application (2021-2032)
- 5.3.3 Global Sanger Sequencers Revenue Market Share by Application (2021-2032)
6 Global Sanger Sequencers Sales by Region
- 6.1 Global Sanger Sequencers Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sanger Sequencers Sales by Region (2021-2032)
- 6.2.1 Global Sanger Sequencers Sales by Region (2021-2026)
- 6.2.2 Global Sanger Sequencers Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sanger Sequencers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sanger Sequencers Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Sanger Sequencers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sanger Sequencers Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sanger Sequencers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sanger Sequencers Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Sanger Sequencers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Sanger Sequencers Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Sanger Sequencers Revenue by Region
- 7.1 Global Sanger Sequencers Revenue by Region
- 7.1.1 Global Sanger Sequencers Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Sanger Sequencers Revenue by Region (2021-2026)
- 7.1.3 Global Sanger Sequencers Revenue by Region (2027-2032)
- 7.1.4 Global Sanger Sequencers Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Sanger Sequencers Revenue (2021-2032)
- 7.2.2 North America Sanger Sequencers Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Sanger Sequencers Revenue (2021-2032)
- 7.3.2 Europe Sanger Sequencers Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Sanger Sequencers Revenue (2021-2032)
- 7.4.2 Asia-Pacific Sanger Sequencers Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Sanger Sequencers Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Sanger Sequencers Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Danaher
- 8.1.1 Danaher Company Information
- 8.1.2 Danaher Business Overview
- 8.1.3 Danaher Sanger Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Danaher Sanger Sequencers Product Portfolio
- 8.1.5 Danaher Recent Developments
- 8.2 Promega
- 8.2.1 Promega Company Information
- 8.2.2 Promega Business Overview
- 8.2.3 Promega Sanger Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Promega Sanger Sequencers Product Portfolio
- 8.2.5 Promega Recent Developments
- 8.3 Denogen (Beijing) Bio-Sci&Tech
- 8.3.1 Denogen (Beijing) Bio-Sci&Tech Company Information
- 8.3.2 Denogen (Beijing) Bio-Sci&Tech Business Overview
- 8.3.3 Denogen (Beijing) Bio-Sci&Tech Sanger Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Denogen (Beijing) Bio-Sci&Tech Sanger Sequencers Product Portfolio
- 8.3.5 Denogen (Beijing) Bio-Sci&Tech Recent Developments
- 8.4 Ningbo HEALTH Gene Technologies
- 8.4.1 Ningbo HEALTH Gene Technologies Company Information
- 8.4.2 Ningbo HEALTH Gene Technologies Business Overview
- 8.4.3 Ningbo HEALTH Gene Technologies Sanger Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Ningbo HEALTH Gene Technologies Sanger Sequencers Product Portfolio
- 8.4.5 Ningbo HEALTH Gene Technologies Recent Developments
- 8.5 Thermo Fisher Scientific
- 8.5.1 Thermo Fisher Scientific Company Information
- 8.5.2 Thermo Fisher Scientific Business Overview
- 8.5.3 Thermo Fisher Scientific Sanger Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Thermo Fisher Scientific Sanger Sequencers Product Portfolio
- 8.5.5 Thermo Fisher Scientific Recent Developments
- 8.6 Superyears Gene
- 8.6.1 Superyears Gene Company Information
- 8.6.2 Superyears Gene Business Overview
- 8.6.3 Superyears Gene Sanger Sequencers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Superyears Gene Sanger Sequencers Product Portfolio
- 8.6.5 Superyears Gene Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Sanger Sequencers Value Chain Analysis
- 9.1.1 Sanger Sequencers Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Sanger Sequencers Production Mode & Process
- 9.2 Sanger Sequencers Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sanger Sequencers Distributors
- 9.2.3 Sanger Sequencers Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst